Chaoju Eye Care Holdings Limited reported a modest contraction in its share base for March 2026, driven entirely by on-market repurchases and subsequent cancellations of 2.33 million ordinary shares.

At 31 March 2026, total issued shares stood at 705.18 million, down 0.33% from 707.51 million a month earlier. No treasury shares were outstanding after the transactions, indicating that all repurchased stock was immediately cancelled.

Authorised capital was unchanged at 1.52 billion ordinary shares with a par value of HKD0.00025 each, equivalent to HKD0.38 million in authorised share capital.

The company confirmed compliance with the Hong Kong Main Board’s minimum public-float requirement of 25% as at month-end.

No movements were recorded under share option schemes, warrants, convertibles or other equity-linked arrangements during the period.

Executive Director and Joint Company Secretary Zhang Guangdi submitted the monthly return on 2 April 2026.